EG19889A - Contrast media - Google Patents

Contrast media

Info

Publication number
EG19889A
EG19889A EG13791A EG13791A EG19889A EG 19889 A EG19889 A EG 19889A EG 13791 A EG13791 A EG 13791A EG 13791 A EG13791 A EG 13791A EG 19889 A EG19889 A EG 19889A
Authority
EG
Egypt
Prior art keywords
concn
esp
dissolved
sodium
pref
Prior art date
Application number
EG13791A
Other languages
English (en)
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10682193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG19889(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP90200580A external-priority patent/EP0390242B1/fr
Application filed by Nycomed As filed Critical Nycomed As
Application granted granted Critical
Publication of EG19889A publication Critical patent/EG19889A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Liquid Crystal (AREA)
  • Devices For Indicating Variable Information By Combining Individual Elements (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Lubricants (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
EG13791A 1990-03-09 1991-03-09 Contrast media EG19889A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90200580A EP0390242B1 (fr) 1989-03-17 1990-03-09 Agents de contraste
GB909020091A GB9020091D0 (en) 1990-09-14 1990-09-14 Contrast media

Publications (1)

Publication Number Publication Date
EG19889A true EG19889A (en) 1996-03-31

Family

ID=10682193

Family Applications (1)

Application Number Title Priority Date Filing Date
EG13791A EG19889A (en) 1990-03-09 1991-03-09 Contrast media

Country Status (32)

Country Link
US (2) US5328680A (fr)
EP (1) EP0521880B2 (fr)
JP (1) JP3215703B2 (fr)
KR (1) KR100189271B1 (fr)
CN (1) CN1055864C (fr)
AT (1) ATE141519T1 (fr)
CA (1) CA2076861A1 (fr)
CZ (1) CZ285071B6 (fr)
DE (1) DE69121562T3 (fr)
DK (1) DK0521880T4 (fr)
DZ (1) DZ1506A1 (fr)
EG (1) EG19889A (fr)
ES (1) ES2090315T5 (fr)
FI (1) FI100698B (fr)
GB (1) GB9020091D0 (fr)
GE (1) GEP19971155B (fr)
GR (2) GR3020842T3 (fr)
HK (1) HK1003563A1 (fr)
HR (1) HRP930773B1 (fr)
HU (1) HU217075B (fr)
IE (1) IE76916B1 (fr)
IL (1) IL97455A (fr)
LV (1) LV10058B (fr)
MY (1) MY105493A (fr)
NO (1) NO304352B1 (fr)
OA (1) OA09667A (fr)
PT (1) PT96978B (fr)
RO (1) RO111543B1 (fr)
SK (1) SK278621B6 (fr)
TR (1) TR25738A (fr)
WO (1) WO1991013636A1 (fr)
YU (1) YU48683B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1256248B (it) * 1992-12-24 1995-11-29 Bracco Spa Formulazioni iniettabili acquose per radiodiagnostica comprendenti miscele di composti aromatici iodurati utili come agenti opacizzanti ai raggi x
GB9419206D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
ES2208884T3 (es) * 1996-01-25 2004-06-16 Schering Aktiengesellschaft Soluciones mejoradas de agentes de contraste para la administracion intravasal.
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
DE10126405A1 (de) * 2001-05-22 2003-02-27 Trommsdorff Gmbh & Co Physiologisch verträgliche Kalium- und Magnesiumsalze enthaltendes pharmazeutisches Präparat sowie dessen Verwendung zur Prophylaxe und/oder Therapie von QT-Zeitverlängerungen
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
DE102005028882A1 (de) * 2005-06-22 2007-01-04 Siemens Ag Lösung und Verfahren zum Unterstützen der Bildgebung an einem Patienten
DE602007012208D1 (de) 2006-02-15 2011-03-10 Ge Healthcare As Kontrastmittel
WO2007111515A2 (fr) * 2006-03-29 2007-10-04 Ge Healthcare As Procede de production de carboxylates et sulfonates hyperpolarises
FR2899581B1 (fr) * 2006-04-07 2008-06-27 Guerbet Sa Procede d'atomisation du ioxilan
US7662859B2 (en) 2007-02-16 2010-02-16 Ge Healthcare As Contrast agents
CN103980154B (zh) 2007-07-12 2015-02-25 通用电气医疗集团股份有限公司 造影剂
US8202511B2 (en) 2007-10-12 2012-06-19 Ge Healthcare As Contrast agents
JP2011500530A (ja) 2007-10-12 2011-01-06 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
ES2413160T3 (es) 2007-10-12 2013-07-15 Ge Healthcare As Agentes de contraste
CN101820922A (zh) 2007-10-12 2010-09-01 通用电气医疗集团股份有限公司 对比剂
CN102271715A (zh) 2009-01-09 2011-12-07 通用电气医疗集团股份有限公司 对比剂组合物
EP2243767A1 (fr) 2009-04-21 2010-10-27 Bracco Imaging S.p.A Procédé d'iodation de composés aromatiques
CN102596257B (zh) 2009-10-29 2013-08-21 通用电气医疗集团股份有限公司 包含具有优良安全性概况的血浆阳离子的诊断组合物
CN102114249B (zh) * 2009-12-30 2013-01-30 四川大学华西医院 一种携氧冠脉造影剂及其制备方法
US20140065076A1 (en) * 2012-08-30 2014-03-06 Otsuka Pharmaceutical Co. Ltd. Container with concentrated substance and method of using the same
MX2015013658A (es) 2013-03-27 2016-02-18 Ge Healthcare As Metodo y reactivo para preparar una composicion diagnostica.
US20150151008A1 (en) * 2013-12-04 2015-06-04 Hovione Scientia Limited Contrast Media Taste Masking Formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1858142A (en) * 1928-01-21 1932-05-10 Nat Aniline & Chem Co Inc Colloidal mono-sodium tetraiodophenolphthalein
NL127881C (fr) * 1963-03-25
US3175952A (en) * 1963-05-29 1965-03-30 Sterling Drug Inc Aqueous radiopaque solutions containing sodium and calcium ions
GB1069437A (en) * 1963-10-23 1967-05-17 Nyegaard & Co As Injectable x-ray contrast media
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
DE2928417A1 (de) * 1979-07-12 1981-01-29 Schering Ag Trijodierte basen
DE3038853A1 (de) * 1980-10-10 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue n-hydroxy-alkylierte dicarbonsaeure-bis-(3,5-dicarbamoyl-2,4,6-trijodanilide), deren herstellung und diese enthaltende roentgenkonstrastmittel (ii)
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
EP0187817B1 (fr) * 1984-06-22 1992-02-05 VEECH, Richard L. Solutions electrolytiques contenant des materiaux polyanioniques
US4663289A (en) * 1984-06-22 1987-05-05 Veech Richard L Electrolyte solutions and in vitro use thereof
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
JPH0625094B2 (ja) * 1988-03-01 1994-04-06 マリンクロット，インコーポレイテッド 非イオン性ｘ線コントラスト剤、組成物及び方法
US5011925A (en) * 1989-03-09 1991-04-30 Mallinckrodt, Inc. Morpholinoamido EDTA derivatives
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions

Also Published As

Publication number Publication date
HU217075B (hu) 1999-11-29
EP0521880B1 (fr) 1996-08-21
CS9100619A2 (en) 1991-09-15
HU9202870D0 (en) 1992-11-30
IE76916B1 (en) 1997-11-05
FI923962A0 (fi) 1992-09-04
RO111543B1 (ro) 1996-11-29
LV10058A (lv) 1994-05-10
PT96978B (pt) 2001-07-31
TR25738A (tr) 1993-09-01
LV10058B (en) 1994-10-20
ES2090315T3 (es) 1996-10-16
GB9020091D0 (en) 1990-10-24
DK0521880T3 (da) 1996-09-09
MY105493A (en) 1994-10-31
CN1055864C (zh) 2000-08-30
YU40891A (sh) 1994-04-05
AU7345191A (en) 1991-10-10
NO923485D0 (no) 1992-09-08
PT96978A (pt) 1991-10-31
YU48683B (sh) 1999-06-15
EP0521880A1 (fr) 1993-01-13
DE69121562T3 (de) 2000-11-23
SK278621B6 (en) 1997-11-05
KR100189271B1 (ko) 1999-06-01
AU645544B2 (en) 1994-01-20
DZ1506A1 (fr) 2004-09-13
JP3215703B2 (ja) 2001-10-09
HUT62490A (en) 1993-05-28
CA2076861A1 (fr) 1991-09-10
HRP930773B1 (en) 2000-10-31
IL97455A (en) 1995-11-27
CZ285071B6 (cs) 1999-05-12
FI100698B (fi) 1998-02-13
NO304352B1 (no) 1998-12-07
EP0521880B2 (fr) 2000-05-31
GR3020842T3 (en) 1996-11-30
JPH05504953A (ja) 1993-07-29
FI923962A (fi) 1992-09-04
GR3033898T3 (en) 2000-11-30
DK0521880T4 (da) 2000-09-04
ATE141519T1 (de) 1996-09-15
HK1003563A1 (en) 1998-10-30
IL97455A0 (en) 1992-06-21
IE910775A1 (en) 1991-09-11
DE69121562D1 (de) 1996-09-26
US5328680A (en) 1994-07-12
NO923485L (no) 1992-11-05
ES2090315T5 (es) 2000-08-01
HRP930773A2 (en) 1997-10-31
WO1991013636A1 (fr) 1991-09-19
CN1056058A (zh) 1991-11-13
OA09667A (en) 1993-05-15
DE69121562T2 (de) 1997-01-16
GEP19971155B (en) 1997-08-11
USRE36418E (en) 1999-11-30

Similar Documents

Publication Publication Date Title
EG19889A (en) Contrast media
KR930021248A (ko) 정수용재, 이의 제조 방법 및 정수방법
HU9501850D0 (en) Aqueous injectable formulations useful for radio-diagnosis comprising iodinated aromatic compounds used as x-ray contrast media
DK0861661T3 (da) Osmotisk middel til peritoneal dialyse
EP1078636A4 (fr) Nouvelle composition pharmaceutique pour traitement d'urgence et son procede de preparation
GR3019922T3 (en) Disinfecting and cleaning composition for contact lenses
KR920700701A (ko) 조영제
EP0153992A3 (en) Water soluble derivatives of 3,5-diaceto amido-2,4,6-triiodobenzoic acid and process for their preparation and use
CO4940495A1 (es) Composiciones solubilizadas de sertralina
NZ234066A (en) A method of purifying water containing aluminium by adding alkali and a source of silicon
GB9426417D0 (en) Body fluid replacement solution
Scott et al. Bioconcentration of Bromoform by American Oysters, Crassostrea virginica(G.), Exposed to Chlorinated and Dechlorinated Seawater, with Notes on Survival and Feeding
Thompson et al. Tolerance and synthetic ability of sewage microorganisms in acid mine water
CA1274441C (fr) Tablettes d'hypochlorite de calcium hydrate contenant de la chaux, utilisees comme lubrifiants et comme retardateurs de solubilisation
JPH1085775A (ja) 浴水の浄化方法及び浴水の浄化システム
UA42070C2 (uk) Спосіб лікування шлунково-кишкових розладів у новонароджених телят
RU96113707A (ru) Питательная среда для культивирования эшерихий